Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company TopiVert Ltd.
DescriptionAnti-inflammatory narrow spectrum kinase inhibitor (NSKI) with small systemic uptake
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentIND
Standard IndicationDry eye
Indication DetailsTreat dry eye syndrome (DES)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today